Skip to main content

Table 3 Comparison of the main outcomes before and after intervention between both groups

From: Vitamin D status is associated with skin autofluorescence in patients with type 2 diabetes mellitus: a preliminary report

Variable

Vitamin D group (n = 107)

Placebo group (n = 103)

β (95% CIs)

p value

0 month

6 months

0 month

6 months

Serum 25(OH)D (nmol/l)

60.8 ± 23.0

103.6 ± 25.7

61.0 ± 23.4

60.3 ± 26.5

42.5 (35.8–49.6)

<0.01

AGE-value

2.67 ± 0.64

2.73 ± 0.69

2.63 ± 0.53

2.74 ± 0.56

−0.05 (−0.17 to 0.08)

0.47

BMI (kg/m2)

28.8 ± 4.8

29.1 ± 4.4

28.7 ± 4.7

28.8 ± 4.8

0.23 (0.01–0.46)

0.04

HbA1c (mmol/mol)

51.1 ± 6.0

50.0 ± 6.3

50.3 ± 5.3

49.4 ± 6.2

1.2 (−0.1 to 2.6)

0.07

  1. 25(OH)D 25-hydroxyvitamin D, AGE advanced glycation end product, BMI body mass index.